Medicare Coverage For Lilly’s Tirzepatide Could Be ‘Unlocked’ With Heart Failure, Apnea Claims

 
• By Cathy Kelly
  
Lilly Drug Could Be Approved In Obesity By Late 2023 • Source: Shutterstock

More from Market Access

More from Pink Sheet